MarketInOut Stock Screener Log In | Sign Up

Microbix Biosystems Inc

TSX • Healthcare • Biotechnology • Quote as of 10/27/2026 09:30
Microbix Biosystems Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeTSX
Market Capitalization43.83 mln
Float114 mln
Earnings Date08/13/2026

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-2.55
Likely reliable

Relative Strength

71 / 100
Outperforming

Debt / Equity

0.28
Very low leverage

Pre-Tax Margin

-32%
Deeply loss-making

ROE

-18.35
Negative

Business Description

Founded in 1988 and based in Mississauga, Canada, Microbix Biosystems supplies essential materials and products to the global diagnostics industry, including test ingredients, quality control products, and sample collection media used to detect infectious diseases. The company also produces Kinlytic, a drug designed to dissolve blood clots, and offers vial filling services to other businesses. Microbix sells its products across North America, Europe, and other international markets.

Key Fundamentals

EPS-0.04
ROE-18.35
RPS0.11
ROIC-17.03
ROA-13.44
Interest Cover-5.68
EBITDA, mln-2.07
EV / EBITDA-19.77
EV / EBIT-10.39
Revenue, mln15.40
EV / Revenue2.65

Quote Details

Last 0.305
Change -0.01 (-3.17%)
Open 0.305
Volume 7,032
Turnover 2,144.76
Average Volume 20,742

Financial Ratios

Pre-Tax Profit Margin-32
Leverage Ratio1.40
Current Ratio6.89
Price / Book1.78
Price / Tangible Book2.10
Debt / Equity0.28
Price / Sales2.84

Financial Strength

Altman Z-Score1.62
Piotroski F-Score 2 / 9
Beneish M-Score-2.55
Price to Intrinsic Value2.63
Short Ratio1.47

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -4.69% 95 / 100   
1 Month 1.67% 80 / 100   
2 Months -1.61% 60 / 100   
6 Months 24.49% 94 / 100   
1 Year 19.61% 72 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog